These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 30718452)

  • 21. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
    Zhao X; Chen GQ; Cao GM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
    Wu WR; Sun H; Zhang R; Yu XH; Shi XD; Zhu MS; Zeng H; Yan LX; Xu LB; Liu C
    Oncotarget; 2016 Apr; 7(14):18684-93. PubMed ID: 26919246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
    Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
    Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
    Carcinogenesis; 2012 May; 33(5):1113-20. PubMed ID: 22362728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma.
    Che J; Su Z; Yang W; Xu L; Li Y; Wang H; Zhou W
    Dig Liver Dis; 2023 Mar; 55(3):412-421. PubMed ID: 35853821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
    Zeng Y; Xu Q; Xu N
    Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S; Wang L; Yao B; Liu Q; Guo C
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
    Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
    Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-758-3p suppresses proliferation, migration and invasion of hepatocellular carcinoma cells via targeting MDM2 and mTOR.
    Jiang D; Cho WC; Li Z; Xu X; Qu Y; Jiang Z; Guo L; Xu G
    Biomed Pharmacother; 2017 Dec; 96():535-544. PubMed ID: 29032337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
    Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
    J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis.
    Li Y; Ren M; Zhao Y; Lu X; Wang M; Hu J; Lu G; He S
    Oncol Rep; 2017 Jun; 37(6):3527-3535. PubMed ID: 28440439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
    Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.
    Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G
    Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.